Functional activation of the AKT-mTOR signalling axis in a real-world metastatic breast cancer cohort.
- Published in:
- British Journal of Cancer, 2024, v. 131, n. 9, p. 1543, doi. 10.1038/s41416-024-02852-y
- By:
- Publication type:
- Article
Works by Dunetz, Rick
Results: 2
1
2
AKT/mTOR signaling modulates resistance to endocrine therapy and CDK4/6 inhibition in metastatic breast cancers.
- Published in:
- NPJ Precision Oncology, 2023, v. 7, n. 1, p. 1, doi. 10.1038/s41698-023-00360-5
- By:
- Publication type:
- Article